Form 4 for CCCC C4 Therapeutics, Inc.
Accepted 2024-11-12 00:00:00 ET · period of report 2024-11-07 · accession 0001662579-24-000101 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-12 | 2024-11-07 | CCCC | Siegel Jolie | CLO | F - Tax | $6.04 | -1,102 | 56.5K | -2% | -$6,656 |
| D | 2024-11-12 | 2024-11-07 | CCCC | Siegel Jolie | CLO | M - OptEx | — | +3,750 | 57.6K | +7% | — |
| D | 2024-11-12 | 2024-11-07 | CCCC | Siegel Jolie | CLO | M - OptEx | $0.00 | -3,750 | 10.5K | -26% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-07 | F | D | 1,102 | $6.04 | 56,488 | D | — | — | |
| 2 | Common | Common Stock | 2024-11-07 | M | A | 3,750 | — | 57,590 | D | — | — | (F1) Each performance restricted stock unit ("PRSU") represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 4,500 PRSUs shall vest upon satisfaction of three escalating share price vesting milestones, and the remaining PRSUs vest upon satisfaction of certain discovery and clinical milestones. |
| 3 | Derivative | Performance Restricted Stock Units | 2024-11-07 | M | D | 3,750 | $0.00 | 10,500 | D | — · — to 2025-02-28 | 3,750 Common Stock | (F1) Each performance restricted stock unit ("PRSU") represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 4,500 PRSUs shall vest upon satisfaction of three escalating share price vesting milestones, and the remaining PRSUs vest upon satisfaction of certain discovery and clinical milestones. |